03:52 AM EDT, 09/19/2025 (MT Newswires) -- Reviva Pharmaceuticals ( RVPH ) said Thursday it has priced a public offering of 27 million shares together with accompanying series E warrants to purchase up to 27 million and series F warrants to purchase up to 27 million shares $0.335 per share and accompanying warrants.

Gross proceeds are estimated to be $9 million and the offering is expected to close Monday, the company said.

The company plans to use net proceeds from the offering to fund research and development and for general corporate purposes.

Shares of the company fell more than 27% in after-hours activity.

Price: 0.30, Change: -0.12, Percent Change: -27.52